HLF
NYSEHERBALIFE LTD.
Consumer Defensive · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
$5.8B
2021
$5.2B
2022
$5.1B
2023
$5.0B
2024
$5.0B
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$5.0B
Net Income$227.8M
Gross Profit$3.9B
Oper Income$481.0M
EPS (dil)$2.20
Rev/sh$48.59
FCF/sh$2.44
Book/sh$-4.91
Gross M77.9%
Oper M9.5%
Profit M4.5%
FCF M5.0%
ROE-44.7%
ROA8.2%
ROIC35.3%
R&D/Rev—
Rev Y/Y0.9%
Rev 3Y CAGR-1.1%
EPS Y/Y-12.0%
EPS 3Y CAGR-12.0%
FCF 3Y CAGR8.8%
Payout0%
Div/sh$0.30
Shs Chg Y/Y+2%
Current Ratio1.13
Quick Ratio0.62
Debt/Eq-3.95
Int Coverage2.2×
Net Debt$1.6B
Total Debt$2.0B
Cash & Eq$375.3M
Total Assets$2.8B
Oper CF$333.3M
Capex$80.4M
Free CF$252.9M
Buybacks$8.2M
Equity$-509.4M
Liabilities$3.3B
Shs Outstand0.10B
SectorConsumer Defensive
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 5 FY| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5.8B | $5.2B | $5.1B | $5.0B | $5.0B |
| Gross Profit | $4.6B | $4.0B | $3.9B | $3.9B | $3.9B |
| Operating Income | $734.1M | $545.2M | $356.4M | $385.9M | $481.0M |
| Net Income | $447.2M | $321.3M | $142.2M | $254.3M | $227.8M |
| Diluted EPS | $4.13 | $3.23 | $1.42 | $2.50 | $2.20 |
| Operating Cash Flow | $460.3M | $352.5M | $357.5M | $285.4M | $333.3M |
| Free Cash Flow | $308.9M | $196.1M | $222.5M | $163.4M | $252.9M |
COMMUNITY · $HLF0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.